RecruitingNot ApplicableNCT03215836

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics


Sponsor

University of Colorado, Denver

Enrollment

50 participants

Start Date

Aug 10, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this pilot study is to determine whether obesity and metabolic syndrome are in fact synergistic in relation to airway nitric oxide (NO) biology. To do so, the investigators want to determine how obesity and the metabolic syndrome relate to metabolism in bronchial airway epithelial cells and the nasal epithelium.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how obesity and metabolic problems (like high blood sugar or insulin resistance) affect the cells lining the airways in people with asthma, compared to people without asthma. **You may be eligible if...** - You are between 18 and 65 years old - You have a doctor's diagnosis of asthma OR you are a healthy non-asthmatic participant - You have smoked fewer than 10 packs per year total, and have not smoked in the past year - You may participate even if you take blood pressure medication or manage diabetes through diet and exercise only **You may NOT be eligible if...** - You currently smoke or have significant smoking history (more than 10 pack-years) - You have a serious medical condition beyond asthma - You are pregnant - You use insulin or diabetes medications beyond diet and exercise control Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBronchoscopy and Nasal Epithelium Brush Sampling

After meeting screening criteria, participants will undergo further evaluation to determine whether or not inclusion and exclusion criteria are met. Participants will undergo a baseline evaluation, lung function testing and a subsequent bronchoscopy and nasal epithelial brush sampling in those that meet study enrollment.


Locations(1)

University of Colorado

Aurora, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03215836


Related Trials